C

Cresco Labs Inc
OTC:CRLBF

Watchlist Manager
Cresco Labs Inc
OTC:CRLBF
Watchlist
Price: 1.19 USD Market Closed
Market Cap: 407.2m USD

Relative Value

The Relative Value of one CRLBF stock under the Base Case scenario is hidden USD. Compared to the current market price of 1.19 USD, Cresco Labs Inc is hidden .

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CRLBF Relative Value
HIDDEN
Show
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
79
vs Industry
86
Median 3Y
1.1
Median 5Y
1.2
Industry
2.6
Forward
0.9
vs History
vs Industry
Median 3Y
-5.7
Median 5Y
-7.3
Industry
21.4
Forward
-7.6
vs History
42
vs Industry
51
Median 3Y
13.1
Median 5Y
14.3
Industry
16.4
vs History
vs Industry
Median 3Y
-4.8
Median 5Y
-1
Industry
22.8
vs History
68
vs Industry
73
Median 3Y
1.5
Median 5Y
1.8
Industry
2.2
vs History
82
vs Industry
70
Median 3Y
1.7
Median 5Y
1.9
Industry
2.9
Forward
1.5
vs History
82
vs Industry
70
Median 3Y
3.5
Median 5Y
4.1
Industry
5.5
vs History
74
vs Industry
48
Median 3Y
8.7
Median 5Y
14.2
Industry
13
Forward
6.5
vs History
68
vs Industry
44
Median 3Y
14.4
Median 5Y
23.5
Industry
16.5
Forward
13.9
vs History
42
vs Industry
42
Median 3Y
21.8
Median 5Y
22.7
Industry
15.6
vs History
9
vs Industry
30
Median 3Y
9.5
Median 5Y
-29.9
Industry
18.7
vs History
84
vs Industry
70
Median 3Y
1
Median 5Y
1.2
Industry
1.9

Multiples Across Competitors

CRLBF Competitors Multiples
Cresco Labs Inc Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Cresco Labs Inc
OTC:CRLBF
862m USD 0.9 -12 7.8 13
US
Eli Lilly and Co
NYSE:LLY
997.6B USD 16.8 54.2 36.4 39
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
494.8B USD 5.4 19.7 16.1 20.9
CH
Roche Holding AG
SIX:ROG
263.6B CHF 4.3 28 11.9 13.9
UK
AstraZeneca PLC
LSE:AZN
218.4B GBP 5.1 31.5 109.5 160.2
CH
Novartis AG
SIX:NOVN
214.5B CHF 4.8 18.8 11.9 15.4
US
Merck & Co Inc
NYSE:MRK
270.7B USD 4.2 14.2 10.1 12
DK
Novo Nordisk A/S
CSE:NOVO B
1.6T DKK 5.2 15.7 11 12.7
IE
Endo International PLC
LSE:0Y5F
213.9B USD 92.2 -73.2 338.7 849.2
US
Pfizer Inc
NYSE:PFE
146.1B USD 2.3 14.9 7.6 10.3
P/E Multiple
Earnings Growth PEG
US
C
Cresco Labs Inc
OTC:CRLBF
Average P/E: 24.6
Negative Multiple: -12
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
54.2
54%
1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
19.7
29%
0.7
CH
Roche Holding AG
SIX:ROG
28
29%
1
UK
AstraZeneca PLC
LSE:AZN
31.5
37%
0.9
CH
Novartis AG
SIX:NOVN
18.8
17%
1.1
US
Merck & Co Inc
NYSE:MRK
14.2
15%
0.9
DK
Novo Nordisk A/S
CSE:NOVO B
15.7
3%
5.2
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -73.2 N/A N/A
US
Pfizer Inc
NYSE:PFE
14.9
27%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
C
Cresco Labs Inc
OTC:CRLBF
Average EV/EBITDA: 400.7
7.8
0%
N/A
US
Eli Lilly and Co
NYSE:LLY
36.4
34%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
16.1
9%
1.8
CH
Roche Holding AG
SIX:ROG
11.9
5%
2.4
UK
AstraZeneca PLC
LSE:AZN
109.5
10%
10.9
CH
Novartis AG
SIX:NOVN
11.9
6%
2
US
Merck & Co Inc
NYSE:MRK
10.1
6%
1.7
DK
Novo Nordisk A/S
CSE:NOVO B
11
1%
11
IE
E
Endo International PLC
LSE:0Y5F
338.7
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.6
0%
N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
C
Cresco Labs Inc
OTC:CRLBF
Average EV/EBIT: 1 713.5
13
28%
0.5
US
Eli Lilly and Co
NYSE:LLY
39
36%
1.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
20.9
15%
1.4
CH
Roche Holding AG
SIX:ROG
13.9
6%
2.3
UK
AstraZeneca PLC
LSE:AZN
160.2
23%
7
CH
Novartis AG
SIX:NOVN
15.4
12%
1.3
US
Merck & Co Inc
NYSE:MRK
12
8%
1.5
DK
Novo Nordisk A/S
CSE:NOVO B
12.7
0%
N/A
IE
E
Endo International PLC
LSE:0Y5F
849.2
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.3
7%
1.5